Epix AI invited to “Unlocking the Epigenome”, an international conference of the Bulgarian Academy of Sciences
CEO Nikolay Vasev presented the company’s progress and services at the international symposium, organized by the Roumen Tsanev Institute of Molecular Biology in Sofia.
Epix AI was invited to take part in “Unlocking the Epigenome: New Horizons in Molecular Medicine and Rare Diseases”, an international symposium of the Bulgarian Academy of Sciences (BAS), organized by the Roumen Tsanev Institute of Molecular Biology in Sofia on 20–21 October 2026.
As a spin-off of BAS and Bulgaria’s first genetic and epigenetic testing company, Epix AI is the leading innovator in epigenetic research in the country, and is democratizing access to this cutting-edge technology in the field of longevity.
Our CEO, Nikolay Vasev, gave a presentation on the company’s progress and services.
This was a major international conference, with participants from the UK, Germany, France and other European countries.
More about the symposium on the Institute of Molecular Biology website.